EIR AstraZeneca Pharmaceuticals LP Jun 2012

Anita Michael FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Wilmington, DE, United States facility and issued inspectional observation (via FDA 483) on 18 Jun 2012.

Product details

  • Category:
  • Inspection end: 18 Jun 2012
  • Location: Wilmington, United States
  • FEI: 2518137
Add To Cart